Moldova Marks World Cancer Day 2026
National TV Outreach and Survivor Engagement
World Cancer Day
On the occasion of World Cancer Day (4 February 2026), the EUCanScreen partner in the Republic of Moldova — IMSP Institutul Oncologic (IMSPIO) — carried out public awareness and dissemination activities focused on cancer prevention and early detection.
IMSPIO
Dr. Ruslan Baltaga, Director of IMSP Institutul Oncologic (IMSPIO) and National Coordinator of the EU-co-funded EUCanScreen project, was invited live on the national television channel Moldova 1 during the morning program “Bună Dimineața.” The main topic of the broadcast was cancer prevention, and among other subjects discussed were the objectives of the EUCanScreen project, the benefits of IMSPIO’s participation in the consortium, and the importance of international knowledge exchange. The intervention highlighted opportunities for medical professionals from the Republic of Moldova to learn about and apply modern screening methodologies used by EU partners.
Dissemination
The national TV appearance supported broad public dissemination, helping deliver key prevention and screening messages to a nationwide audience and raising awareness about the added value of Moldova’s participation in EU thematic health programmes.
Sharing Personal Experiences
In parallel, IMSP Institutul Oncologic (IMSPIO) hosted a World Cancer Day event titled “United for Uniqueness – Survivors Speak.” Cancer survivors, healthcare professionals, academics, artists, and public figures shared personal experiences and messages of hope and resilience. Discussions emphasized the importance of psychological support, community solidarity, trust in evidence-based medicine, and timely diagnosis.
Public Awareness
Through these combined media and community outreach actions, IMSP Institutul Oncologic (IMSPIO) contributed to strengthening public awareness and ensuring national-level dissemination of EUCanScreen project goals and benefits.
Subscribe to our newsletter to get news and updates.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959